CLARENTIS Ultra-Lyte® added to N List

Ultra-Lyte® was added by the  US EPA to the N list, so it can be used against SARS-CoV-2 (Covid-19), after Ultra-Lyte® had demonstrated effectiveness against viruses similar to Norovirus (Feline Calicivirus as a surrogate) on hard, non-porous surfaces.

Ultra-Lyte was also approved by Health Canada for use against Sars-CoV-2, and Norovirus, after it had demonstrated effectiveness against both the Human Coronavirus (with Human Corona Virus Strain 229E as a surrogate) and Norovirus ( with Feline Calicivirus as a surrogate).